If you have treatment plans that remain ‘unsold’, you could be sitting on a fortune in unclaimed income.A few reasons why practices ask us to follow up unsold treatment plansIncreased Revenue: Reactivating unsold treatment plans can help a dentist increase their revenue by identifying and addressing previously unmet patient needs. This can provide an opportunity for the dentist to offer additional treatments or procedures that the patient may have previously declined or overlooked. Improved Patient Retention: Dentists can improve their patient retention rates by re-engaging with patients who may have previously put off recommended treatments. By showing patients the value and importance of recommended treatments, a dentist can build stronger relationships with them and increase patient loyalty. Enhanced Patient Satisfaction: By addressing previously unmet patient needs and providing comprehensive care, a dentist can improve patient outcomes, reduce the need for future treatments, and ultimately provide a better patient experience. Increased Referrals: Satisfied patients are more likely to recommend their dentist to friends and family members, which can result in new patients for the dentist. Professional Fulfillment: Anecdotally, we hear that reactivating unsold treatment plans can provide dentists with a sense of professional fulfilment by allowing them to provide comprehensive care to their patients and address previously unmet needs. This can lead to increased job satisfaction and a sense of pride in one's work. Unsold treatment plan reactivation can be a cost-effective way for dentists to improve their practice's profitability and reputation while also providing necessary care to patients who may have been neglecting their oral health. By identifying and addressing previously unmet patient needs, dentists can improve patient outcomes, increase patient loyalty, and build a stronger, more successful practice.
“When I looked at this with WOMM, we had over £250k in unsold treatment plans going back 3 years. WOMM managed to reactivate around 30% of these and we’re now signing patients that we first saw years ago”